Twist Bioscience (($TWST)) has held its Q4 earnings call. Read on for the main highlights of the call. Twist Bioscience’s recent earnings call ...

Twist Bioscience recently reported fourth-quarter and full-year fiscal 2025 results, highlighting record revenue of US$99.01 million and strong double-digit growth across synthetic biology, biopharma, ...

Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus.

Aytu BioScience (($AYTU)) has held its Q1 earnings call. Read on for the main highlights of the call. Aytu BioScience’s recent earnings call ...

Before becoming the Unabomber, Ted Kaczynski underwent intense psychological experiments at Harvard. Experts question if these studies influenced his bombing spree.  Read More ...

Analysts expect the South San Francisco, California-based company to report quarterly loss at 50 cents per share, versus a ...

Twist reported SynBio revenue of $39.5 million for the quarter, a 17% increase year-over-year, and $145 million for the full year. NGS revenue reached $53 million for the quarter and $208.1 million ...

The MarketWatch News Department was not involved in the creation of this content.-- AI virtual cells outperform key baselines on well-calibrated metrics, challenging prior reports ...

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government leaders, indicate that Arizona's 2002 investment in TGEN has lived up to ...

HOLLISTON, Mass. (AP) — HOLLISTON, Mass. (AP) — Harvard Bioscience Inc. (HBIO) on Thursday reported a loss of $1.2 million in its third quarter. The Holliston, Massachusetts-based company said it had ...

Discover Q3 2025 earnings insights for Harvard Bioscience—learn about margin gains, product launches, and demand trends.

TORONTO (AP) — TORONTO (AP) — Satellos Bioscience Inc. (MSCLF) on Friday reported a loss of $5.8 million in its third quarter. On a per-share basis, the Toronto-based company said it had a loss of 3 ...